马里兰州处方药品可负担性委员会批准计划,以限制州和地方政府支付高价药品。 Maryland's Prescription Drug Affordability Board approves plan to cap state & local government payments for high-cost drugs.

马里兰州处方药品支付能力委员会已经获得批准,以执行一项计划,为州和地方政府支付高价处方药品规定上限。 Maryland's Prescription Drug Affordability Board has received approval to implement a plan that caps payments for high-cost prescription drugs for state and local governments. 立法委员会投票16-5赞成,目的是提高药物的可负担性和获得药物的机会。 The legislative committee voted 16-5 in favor, aiming to enhance drug affordability and access. 委员会将审查具体药品,并与制造商谈判定价问题。 The board will review specific drugs and negotiate pricing with manufacturers. 支持者希望今后扩大这一倡议,使马里兰所有居民受益。 Supporters hope to expand this initiative in the future to benefit all Maryland residents.